This site is intended for Healthcare professionals only.
×

Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension


Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension

Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, announces the launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension, a bioequivalent prescription generic version of Zegerid® Powder for Oral Suspension (20mg/1680mg and 40mg/1680mg), into the US market.

Omeprazole and Sodium Bicarbonate Powder for Oral Suspension is part of an ever-growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 26 Abbreviated New Drug Applications (ANDAs) of which it has 14 final ANDA approvals; 2 tentative approvals; and 10 ANDAs under review with the United States Food & Drug Administration.

The following two tabs change content below.
savita thakur

savita thakur

Studied at Indraprastha College for Women (Delhi University), completed in 2014. Currently working with Medical Dialogues, a online Medical news paper dedicated for healthcare Professionals.


Source: Press Release
0 comment(s) on Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted